ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Cricoid Pressure in Occluding the Esophageal Entrance: A Glidescope ® Study (CP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01415661
Recruitment Status : Completed
First Posted : August 12, 2011
Last Update Posted : April 10, 2012
Sponsor:
Information provided by (Responsible Party):
Ahed ZEIDAN, Procare Riaya Hospital

Brief Summary:
This investigation was designed to assess the patency of the esophageal entrance during cricoid pressure (CP) in anesthetized, paralyzed obese and non obese patients using the Glidescope ® video laryngoscope (GVL).

Condition or disease Intervention/treatment Phase
Aspiration Other: cricoid pressure Not Applicable

Detailed Description:
Eighty-nine patients undergoing surgeries necessitating general anesthesia and tracheal intubation were enrolled in this study. Group 1 (OB) including obese patients (n= 59) was undergoing bariatric surgery. Following rapid sequence induction/intubation (RSII) anesthesia with cricoid pressure, clear view of the vocals cord and the entrance to the esophagus were assessed using Glidescope® video laryngoscope before intubation and following intubation. Following securing the airway, efficacy of cricoid pressure was tested by the capability to insert gastric tubes (20 and 38 Fr) under direct vision using GVL. Group 2 (NOB) including non-obese patients (n=30) was undergoing moderate surgery requiring tracheal intubation under general anesthesia. Efficacy of cricoid pressure was also tested similarly using GT's (20 and 38 Fr) following induction of anesthesia and before intubation. Inability of GT insertion was recorded as non-patent esophagus (effective CP) and successful insertion of GT was recorded as patent esophagus (ineffective CP). Then CP was released and insertion of GT achieved for correct verification of the esophageal opening position in both groups.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 89 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Prevention
Official Title: Efficacy of Cricoid Pressure in Occluding the Esophageal Entrance: A Glidescope ® Study
Study Start Date : January 2011
Actual Primary Completion Date : September 2011
Actual Study Completion Date : September 2011

Arm Intervention/treatment
Experimental: obese patient Other: cricoid pressure
The current study test by direct visual evidence the occlusion of esophageal entrance during application CP. The closure of the lumen was further demonstrated by the inability to introduce a GT into the esophagus during CP.
Other Name: Glidescope
Experimental: non obese patient Other: cricoid pressure
The current study test by direct visual evidence the occlusion of esophageal entrance during application CP. The closure of the lumen was further demonstrated by the inability to introduce a GT into the esophagus during CP.
Other Name: Glidescope



Primary Outcome Measures :
  1. Efficacy of Cricoid Pressure for Prevention of Aspiration [ Time Frame: 24 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Obese patients ( BMI 40-70 kg/m2)
  • No Contre indication to cricoid pressure
  • No-obese patients (BMI < 40)

Exclusion Criteria:

  • ASA 3 and 4
  • Contre indication to cricoid pressure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01415661


Locations
Saudi Arabia
procare Riaya Hospital
Al Khobar, Estern, Saudi Arabia, 31952
Sponsors and Collaborators
Procare Riaya Hospital
Investigators
Study Chair: AHED ZEIDAN, MD Procare Riaya Hospital

Responsible Party: Ahed ZEIDAN, MD, Procare Riaya Hospital
ClinicalTrials.gov Identifier: NCT01415661     History of Changes
Other Study ID Numbers: PRH 01
First Posted: August 12, 2011    Key Record Dates
Last Update Posted: April 10, 2012
Last Verified: April 2012